Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 4/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | CES2 | O00748 | 1/20 | 0.52 |
| ▸ | CES1 | P23141 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | HSD17B3 | P37058 | 5/20 | 0.49 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.49 |
| ▸ | FEN1 | P39748 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4373141 | 1.00 | GAA (0.59) | GAAHDAC3MEN1KMT2AMAPT | |
| SCHEMBL4369180 | 1.00 | GAA (0.59) | GAAHDAC3MEN1KMT2AMAPT | |
| SCHEMBL18825664 | 1.00 | GAA (0.59) | GAAHDAC3MEN1KMT2AMAPT | |
| SCHEMBL18825661 | 1.00 | GAA (0.59) | GAAHDAC3MEN1KMT2AMAPT | |
| SCHEMBL18825687 | 1.00 | GAA (0.59) | GAAHDAC3MEN1KMT2AMAPT | |
| SCHEMBL25222615 | 1.00 | GAA (0.59) | GAAHDAC3MEN1KMT2AMAPT | |
| SCHEMBL10353082 | 1.00 | GAA (0.59) | GAAHDAC3MEN1KMT2AMAPT | |
| SCHEMBL5634680 | 1.00 | GAA (0.59) | GAAHDAC3MEN1KMT2AMAPT | |
| SCHEMBL1531620 | 0.98 | GAA (0.57) | GAAHDAC3MEN1KMT2AMAPT | |
| SCHEMBL3507027 | 0.93 | HDAC3 (0.55) | GAAHDAC3MEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090162312-A1 | NOVEL BIODEGRADABLE BIOFOULING CONTROL COATING AND METHOD OF FORMULATION | THE GOVERNMENT OF THE UNITED STATES, AS RESPRESENTED BY THE SECRETARY OF THE NAVY | 2009-06-25 | — | — | US | claimed |
| US-20070059273-A1 | Novel biodegradable biofouling control coating and method of formulation | U.S.A. AS REPRESENTED BY THE SECRETARY OF THE NAVY, THE | 2007-03-15 | — | — | US | claimed |
| US-20090162312-A1 | NOVEL BIODEGRADABLE BIOFOULING CONTROL COATING AND METHOD OF FORMULATION | THE GOVERNMENT OF THE UNITED STATES, AS RESPRESENTED BY THE SECRETARY OF THE NAVY | 2009-06-25 | — | — | US | disclosed |
| US-20070059273-A1 | Novel biodegradable biofouling control coating and method of formulation | U.S.A. AS REPRESENTED BY THE SECRETARY OF THE NAVY, THE | 2007-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070059273-A1 | Novel biodegradable biofouling control coating and method of formulation | ALG1, CHIT1, BMP2 | GAA 1346/4885HDAC3 214/4885MEN1 2813/4885 |
| US-20090162312-A1 | NOVEL BIODEGRADABLE BIOFOULING CONTROL COATING AND METHOD OF FORMULATION | ALG1, CHIT1, BMP2 | GAA 1346/4885HDAC3 214/4885MEN1 2813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.